Fresenius Medical Care AG & Co. KGaA (FMS) Earnings History
Annual and quarterly earnings data from 1998 to 2025
Loading earnings history...
FMS EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
FMS Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 25.6% | 9.3% | 5.0% |
| 2024 | 24.6% | 7.2% | 2.8% |
| 2023 | 25.3% | 7.0% | 2.6% |
| 2022 | 25.2% | 7.8% | 3.5% |
| 2021 | 27.1% | 10.5% | 5.5% |
Download Data
Export FMS earnings history in CSV or JSON format
Free sign-in required to download data
Fresenius Medical Care AG & Co. KGaA (FMS) Earnings Overview
As of May 8, 2026, Fresenius Medical Care AG & Co. KGaA (FMS) reported trailing twelve-month net income of $947M, reflecting +82.6% year-over-year growth. The company earned $1.72 per diluted share over the past four quarters, with a net profit margin of 5.0%.
Looking at the long-term picture, FMS's 5-year EPS compound annual growth rate (CAGR) stands at +5.1%, showing solid earnings momentum. The company achieved its highest annual net income of $1.98B in fiscal 2018.
Fresenius Medical Care AG & Co. KGaA maintains positive profitability with a gross margin of 25.6%, operating margin of 9.3%, and net margin of 5.0%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including DVA ($781M net income, 5.5% margin), FXNC ($18M net income, 15.8% margin), NKTR (-$164M net income, -297.1% margin), FMS has room to improve margins relative to the peer group. Compare FMS vs DVA →
FMS Earnings vs Peers
Earnings metrics vs comparable public companies
FMS Historical Earnings Data (1998–2025)
28 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $978M | +81.8% | $1.83B | $1.68 | 5.0% | 9.3% |
| 2024 | $538M | +7.8% | $1.39B | $0.92 | 2.8% | 7.2% |
| 2023 | $499M | -25.9% | $1.37B | $0.85 | 2.6% | 7.0% |
| 2022 | $673M | -30.5% | $1.51B | $0.57 | 3.5% | 7.8% |
| 2021 | $969M | -16.8% | $1.85B | $0.83 | 5.5% | 10.5% |
| 2020 | $1.16B | -2.9% | $2.30B | $1.31 | 6.5% | 12.9% |
| 2019 | $1.20B | -39.5% | $2.27B | $1.35 | 6.9% | 13.0% |
| 2018 | $1.98B | +54.8% | $3.04B | $3.23 | 12.0% | 18.4% |
| 2017 | $1.28B | +8.3% | $2.36B | $2.08 | 7.2% | 13.3% |
| 2016 | $1.18B | +25.6% | $2.51B | $1.87 | 6.9% | 14.7% |
Full FMS Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See FMS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs FMS Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare FMS vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonFMS — Frequently Asked Questions
Quick answers to the most common questions about buying FMS stock.
Is FMS growing earnings?
FMS EPS is $1.72, with earnings growth accelerating to +82.6%. This exceeds the 5-year CAGR of +5.1%. TTM net income reached $947M.
What are FMS's profit margins?
Fresenius Medical Care AG & Co. KGaA net margin is +5.0%, with operating margin at +9.3%. Below-average margins reflect competitive or cost pressures.
How consistent are FMS's earnings?
FMS earnings data spans 1998-2025. The accelerating earnings trend is +82.6% YoY. Historical data enables comparison across business cycles.